DYX1C1 Gene Primary Ciliary Dyskinesia Type 25 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Respiratory Health
The DYX1C1 Gene Primary Ciliary Dyskinesia Type 25 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals suffering from chronic respiratory conditions and related health complications. This advanced genetic screening utilizes state-of-the-art Next-Generation Sequencing (NGS) technology to identify specific mutations in the DYX1C1 gene that are responsible for Primary Ciliary Dyskinesia Type 25 – a rare genetic disorder affecting the structure and function of cilia throughout the body.
What is Primary Ciliary Dyskinesia Type 25?
Primary Ciliary Dyskinesia (PCD) Type 25 is an autosomal recessive genetic disorder characterized by defective ciliary function. Cilia are microscopic, hair-like structures that line the respiratory tract, reproductive system, and other organs. In healthy individuals, these cilia beat in coordinated waves to move mucus, bacteria, and debris out of the airways. When the DYX1C1 gene contains mutations, it disrupts normal ciliary development and function, leading to the accumulation of mucus and increased susceptibility to infections.
What Does This Test Detect?
Our comprehensive NGS genetic test specifically targets and analyzes the DYX1C1 gene to identify:
- Point mutations, deletions, and insertions in the DYX1C1 gene
- Pathogenic variants associated with Primary Ciliary Dyskinesia Type 25
- Genetic changes that disrupt ciliary structure and motility
- Inheritance patterns for family planning purposes
- Both known and novel mutations through comprehensive gene sequencing
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing the following symptoms or clinical presentations:
- Chronic respiratory infections beginning in infancy or early childhood
- Persistent cough with thick mucus production
- Recurrent sinusitis and middle ear infections
- Bronchiectasis (damaged airways)
- Nasal congestion and runny nose present since birth
- Unexplained infertility or ectopic pregnancies
- Situs inversus (organs on opposite side of body)
- Family history of Primary Ciliary Dyskinesia
- Consanguineous parents or affected siblings
Key Benefits of DYX1C1 Genetic Testing
- Definitive Diagnosis: Provides conclusive evidence for Primary Ciliary Dyskinesia Type 25
- Early Intervention: Enables proactive management of respiratory symptoms
- Personalized Treatment: Guides targeted therapies and preventive care
- Family Planning: Identifies carrier status and recurrence risks
- Improved Quality of Life: Reduces hospitalizations through better disease management
- Comprehensive Analysis: Utilizes advanced NGS technology for maximum accuracy
Understanding Your Test Results
Our genetic counselors will provide detailed interpretation of your results:
- Positive Result: Indicates the presence of pathogenic mutations in the DYX1C1 gene, confirming Primary Ciliary Dyskinesia Type 25 diagnosis
- Negative Result: No disease-causing mutations detected, though other genetic or non-genetic causes should be considered
- Variant of Uncertain Significance: Genetic changes with unknown clinical impact requiring further evaluation
- Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | DYX1C1 Gene Primary Ciliary Dyskinesia Type 25 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
| Specialty | ENT Doctor, Genetics Department |
Pre-Test Instructions
Before scheduling your test, we recommend:
- Providing complete clinical history of respiratory symptoms and related conditions
- Undergoing genetic counseling to discuss testing implications and family history
- Completing a pedigree chart documenting affected family members
- Consulting with your ENT specialist or genetic counselor
Nationwide Testing Availability
We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Take Control of Your Respiratory Health Today
Don’t let unexplained respiratory symptoms compromise your quality of life. Our DYX1C1 Gene Primary Ciliary Dyskinesia Type 25 NGS Genetic DNA Test provides the answers you need for proper diagnosis and management. With our discounted price of only $500 USD and comprehensive genetic analysis, you can make informed decisions about your health and future.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive diagnosis and personalized care.
